Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs

Author： Mandel S.   Weinreb O.   Youdim M.B.H.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.4, 2003-04, pp. : 184-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson's Disease

By Ross G.W.  

Drugs & Aging, Vol. 18, Iss. 11, 2001-01 ,pp. : 797-806

Adis International

Access to resources Recommend Favorite

Gene-Expression Profiling of Human Mononuclear Cells from Welders Using cDNA Microarray

By Rim Kyung Taek   Park Kun Koo   Kim Yang Ho   Lee Yong Hwan   Han Jeong Hee   Chung Yong Hyun   Yu Il Je  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 15-16, 2007-01 ,pp. : 1264-1277

Taylor & Francis Ltd

Access to resources Recommend Favorite

Neuroprotective Effects of Tetracyclines: Molecular Targets, Animal Models and Human Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 222-231

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging analgesic drugs for Parkinson's disease

By Perez-Lloret Santiago   Rey María Verónica   Dellapina Estelle   Pellaprat Jean   Brefel-Courbon Christine   Rascol Olivier  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 157-171

Informa Healthcare

Access to resources Recommend Favorite